Stay updated on ImPRESS: Losartan Imaging Perfusion Clinical Trial
Sign up to get notified when there's something new on the ImPRESS: Losartan Imaging Perfusion Clinical Trial page.

Latest updates to the ImPRESS: Losartan Imaging Perfusion Clinical Trial page
- Check5 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check12 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedNo textual changes were reported for this page. The provided data indicates no updates to the content.SummaryDifference0.2%

- Check33 days agoChange DetectedThe study page now displays a 403 Forbidden error, indicating the record cannot be accessed. The visible site chrome remains, but the main content is blocked, signaling an access permissions issue rather than a content update.SummaryDifference21%

- Check54 days agoChange DetectedThe page now includes a 2018 NIH grant/contract note and updates the Revision to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page footer's revision label updated from v3.6.4 to v3.6.5, indicating a version increment of the site's backend/template. This change does not alter the visible content of the study page.SummaryDifference0.0%

Stay in the know with updates to ImPRESS: Losartan Imaging Perfusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ImPRESS: Losartan Imaging Perfusion Clinical Trial page.